Print this page
-
Cutaneous Oncology Clinical Database and Biospecimen Bank
Protocol: 002233Principal Investigator:
-
Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
Video Education with Result Dependent dIsclosure (VERDI)
Protocol: 042207Principal Investigator:
-
Deborah L Toppmeyer
Applicable Disease Sites: Breast
Colon
Kidney
Melanoma, Skin
Ovary
Pancreas
Prostate
Soft Tissue -
Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma.
Protocol: 092202Principal Investigator:
-
Adam Berger
Applicable Disease Sites: Melanoma, Skin -
Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination with Pembrolizumab Versus Investigator's Choice in HLAA*02:01-Positive Participants with Previously Treated Advanced Melanoma.
Protocol: 092203Principal Investigator:
-
Ryan Stephenson
Applicable Disease Sites: Melanoma, Skin -
A Phase I Study to Evaluate the Safety of Naltrexone and Propranolol in Combination with Standard of Care Ipilimumab and Nivolumab in Patients with Advanced Melanoma.
Protocol: 092302Principal Investigator:
-
Ryan Stephenson
Applicable Disease Sites: Melanoma, Skin -
A Phase 2 and Phase 3 Peri-Operative trial of Fianlimab and Cemiplimab Compared with Pembrolizumab in Patients with Resectable Stage III and IV Melanoma.
Protocol: 092303Principal Investigator:
-
Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
NCI 10204 - A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Protocol: 092305Principal Investigator:
-
Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab versus Relatlimab and Nivolumab in Participants with Unresectable or Metastatic Melanoma.
Protocol: 092402Principal Investigator:
-
Sarah Weiss
Applicable Disease Sites: Melanoma, Skin -
Facebook Intervention for Young Onset Melanoma Patients and Families.
Protocol: 131812Principal Investigator:
-
Sharon Manne
Applicable Disease Sites: Melanoma, Skin -
A Multi-Level Investigation of US Indoor Tanning Policy Enactment, Implementation, Compliance, Impact, and Economics.
Protocol: 132005Principal Investigator:
-
Carolyn J Heckman
Applicable Disease Sites: Melanoma, Skin -
Understanding Sun Protection and Skin Examination Practices Among Hispanics.
Protocol: 132111Principal Investigator:
-
Carolyn J Heckman
Applicable Disease Sites: Melanoma, Skin -
A Digital Intervention to Improve Skin Self-Examination Among Melanoma Survivors.
Protocol: 132202Principal Investigator:
-
Sharon Manne
Applicable Disease Sites: Melanoma, Skin